259 Table 10.4: Live Birth Rate for Adenomyosis Severity MRI Markers versus Controls Analysed Subgroup (N) LBR Adenomyosis Cases (%) LBR Control Group (N=889, %) aOR (95% CI)* p-value** Adenomyosis Patients with Myometrial Cysts (n=60) 7 (12.1%) 233 (26.8%) 0.420 (0.177-0.997) 0.049 Adenomyosis Patients without Myometrial Cysts (n=63) 10 (16.1%) 0.556 (0.255-1.214) 0.14 Adenomyosis Patients with Mean JZ<12mm (N= 103) 15 (15.%) 0.510 (0.264-0.985) 0.045 Adenomyosis Patients with Mean JZ>12mm (N= 20) 2 (10.5%) 0.374 (0.082-1.700) 0.20 Adenomyosis Patients with JZ-Diff <5mm (N=13) 1 (7.7%) 0.255 (0.032-2.041) 0.20 Adenomyosis Patients with JZDiff>5mm (N= 110) 16 (15.0%) 0.519 (0.273-0.990) 0.046 Adenomyosis Patients with JZMyometrium <40% (N=31) 5 (16.7%) 0.598 (0.212-1.683) 0.33 Adenomyosis Patients with JZMyometrium Ratio >40% (N=92) 12 (13.3%) 0.453 (0.222-0.921) 0.029 Diffuse Adenomyosis (N=31) 5 (16.7%) 0.583 (0.209-1.201) 0.30 Focal Adenomyosis (N=58) 9 (15.5%) 0.525 (0.230-1.626) 0.13 Adenomyosis Alone (n=31) 5 (17.2%) 0.652 (0.225-1.889) 0.43 Adenomyosis and Endometriosis (n=93) 12 (14.1%)§ 0.440 (0.219-0.886) 0.021 Adenomyosis without DIE (n=98) 15 (15.8%) 0.542 (0.280-1.050) 0.070 Adenomyosis with DIE (n=26) 2 (7.7%)§ 0.272 (0.061-1.212) 0.088 LBR: live birth rate; aOR: adjusted Odds Ratio; DIE: Deep Invasive Endometriosis *Multivariate logistic regression adjusted for: age at time of IVF, IVF or ICSI treatment, embryo quality, year of IVF treatment and number of transferred embryos, **p-value for logistic regression analysis § denotes p<0.05 versus controls in crude analysis
RkJQdWJsaXNoZXIy MTk4NDMw